Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02908399
Other study ID # 2016P000898
Secondary ID
Status Enrolling by invitation
Phase N/A
First received September 8, 2016
Last updated August 28, 2017
Start date October 2016
Est. completion date June 2018

Study information

Verified date August 2017
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective study of up to 250 participants, from birth to 18 months, who have already had a chest x-ray while a patient at the National Institute of Health (NICH) in Karachi, Pakistan. Participants will include both males and females as well as all races and ethnicities. Participants will have thermal pictures of their chest taken by trained study staff using a Smartphone and a FLIR ONE attachment. Thermal images will be read by trained radiologists to determine if bacterial pneumonia is present. Results of the thermal image will then be compared to the results of the chest x-ray. If additional images of the chest or other areas of suspected related infection are available, additional thermal images will be taken of the same location within 24 hours of the other image.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 250
Est. completion date June 2018
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Months
Eligibility Inclusion Criteria:

- 18 months or younger;

- patient at NICH Hospital in Karachi, Pakistan;

- had chest x-ray within last 24 hours to determine diagnosis of bacterial pneumonia;

- consent obtained from one parent

Exclusion Criteria:

- thermal image cannot be done within 24 hours of chest x-ray

Study Design


Intervention

Device:
FLIR ONE


Locations

Country Name City State
Pakistan National Institute of Child Health Karachi

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital United States Agency for International Development (USAID)

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary diagnosis of bacterial pneumonia Pneumonia is defined as the presence of an airspace opacity, lobar consolidation, or interstitial opacities on a chest x-ray. This determination will be made by two independent radiologists blinded to each other's readings, clinical information and thermal images. If they agree that pneumonia is either present or absent, that will be the final diagnosis. If there is disagreement, a third independent, blinded radiologist will break the tie. 24 hours
Secondary diagnosis of additional site of infection possibly related to bacterial pneumonia Thermal imaging will be used to image other potential sites of infection suspected of being related to the bacterial pneumonia if suspected by physician up to a maximum of 28 days after original chest x-ray to diagnose pneumonia is taken
See also
  Status Clinical Trial Phase
Completed NCT02381431 - Use of Mobile Phones for Thermal Imaging of the Chest to Save Lives of Children With Pneumonia in Nagpur, India N/A